Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania 19104-4283
28 studies enrolling now · 401 studies all time
What they study most
A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania, ADVANCED HEPATOCELLULAR CARCINOMA (HCC), AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma, AIDS-related Lymphoblastic Lymphoma, AIDS-related Malignancies, AIDS-related Small Noncleaved Cell Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia
Studies at this site
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — Recruiting now
- A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
- PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer — Recruiting now
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — Recruiting now
- QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer — Recruiting now
- Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance — Recruiting now
- ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer — Recruiting now
- CAR-T Followed by Bispecific Antibodies — Recruiting now
- Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma — Recruiting now
- SynKIR-310 for Relapsed/Refractory B-NHL — Recruiting now
- Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT — Recruiting now
- In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma — Recruiting now
- SBRT With Atezo/Bev for HCC — Recruiting now
- A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
- CTNNA1 Familial Expansion Study — Recruiting now
- Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk — Recruiting now
- Healthy Volunteers Study — Recruiting now
- Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy — Recruiting now
- Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) — Recruiting now
- Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
- Ovarian Tissue Transplantation — Recruiting now
- Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis — Recruiting now
- The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study — Recruiting now
- Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies — Recruiting now
- TmPSMA-02 in mCRPC — Running, not enrolling
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer — Completed
- Endocrine Response in Women With Invasive Lobular Breast Cancer — Completed
- The Breast Program - Translational Cancer Resource — Running, not enrolling
- PDT Plus Vitamin D3 for Anal Dysplasia — Withdrawn before enrolling
- Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer — Running, not enrolling
- Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples — Completed
- Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma. — Running, not enrolling
- PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma — Starting soon
- Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer — Running, not enrolling
- Personalized Radiation Therapy for GBM — Completed
- Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases — Running, not enrolling
- Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases — Enrolling by invitation
- CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer — Running, not enrolling
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
- Itacitinib + Everolimus in Hodgkin Lymphoma — Running, not enrolling
- Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition — Completed
- Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery — Running, not enrolling
- A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence — Running, not enrolling
- ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy — Running, not enrolling
- Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
- A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects — Completed
- FDG PET/CT in Lung Cancer Staging — Completed
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
- Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer — Running, not enrolling
- Cardiovascular Effects of CART Cell Therapy — Completed